175 related articles for article (PubMed ID: 23292357)
1. Interaction of L-SIGN with hepatitis C virus envelope protein E2 up-regulates Raf-MEK-ERK pathway.
Zhao LJ; Wang W; Ren H; Qi ZT
Cell Biochem Biophys; 2013 Jul; 66(3):589-97. PubMed ID: 23292357
[TBL] [Abstract][Full Text] [Related]
2. ERK signaling is triggered by hepatitis C virus E2 protein through DC-SIGN.
Zhao LJ; Wang W; Ren H; Qi ZT
Cell Stress Chaperones; 2013 Jul; 18(4):495-501. PubMed ID: 23378214
[TBL] [Abstract][Full Text] [Related]
3. Activation of p38 MAPK pathway by hepatitis C virus E2 in cells transiently expressing DC-SIGN.
Chen QL; Zhu SY; Bian ZQ; Zhao LJ; Cao J; Pan W; Qi ZT
Cell Biochem Biophys; 2010; 56(1):49-58. PubMed ID: 19851890
[TBL] [Abstract][Full Text] [Related]
4. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase signalling pathways triggered by the hepatitis C virus envelope protein E2: implications for the prevention of infection.
Zhao LJ; Zhao P; Chen QL; Ren H; Pan W; Qi ZT
Cell Prolif; 2007 Aug; 40(4):508-21. PubMed ID: 17635518
[TBL] [Abstract][Full Text] [Related]
6. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2.
Lozach PY; Lortat-Jacob H; de Lacroix de Lavalette A; Staropoli I; Foung S; Amara A; Houles C; Fieschi F; Schwartz O; Virelizier JL; Arenzana-Seisdedos F; Altmeyer R
J Biol Chem; 2003 May; 278(22):20358-66. PubMed ID: 12609975
[TBL] [Abstract][Full Text] [Related]
7. Synthesized peptides 705-734 from hepatitis C virus E2 glycoprotein induce dendritic cell maturation by activating p38 MAPK signaling.
Liu X; Chen N; Lin S; Liu M
Int Immunopharmacol; 2016 Jan; 30():194-201. PubMed ID: 26604090
[TBL] [Abstract][Full Text] [Related]
8. "RAF" neighborhood: protein-protein interaction in the Raf/Mek/Erk pathway.
Cseh B; Doma E; Baccarini M
FEBS Lett; 2014 Aug; 588(15):2398-406. PubMed ID: 24937142
[TBL] [Abstract][Full Text] [Related]
9. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.
Cormier EG; Durso RJ; Tsamis F; Boussemart L; Manix C; Olson WC; Gardner JP; Dragic T
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14067-72. PubMed ID: 15371595
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR.
Pöhlmann S; Zhang J; Baribaud F; Chen Z; Leslie GJ; Lin G; Granelli-Piperno A; Doms RW; Rice CM; McKeating JA
J Virol; 2003 Apr; 77(7):4070-80. PubMed ID: 12634366
[TBL] [Abstract][Full Text] [Related]
11. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors.
Zhao LJ; Wang L; Ren H; Cao J; Li L; Ke JS; Qi ZT
Exp Cell Res; 2005 Apr; 305(1):23-32. PubMed ID: 15777784
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of ERK and p38 MAPK signaling pathways by hepatitis C virus E2 envelope protein in human T lymphoma cell line.
Zhao LJ; Zhang XL; Zhao P; Cao J; Cao MM; Zhu SY; Liu HQ; Qi ZT
J Leukoc Biol; 2006 Aug; 80(2):424-32. PubMed ID: 16793913
[TBL] [Abstract][Full Text] [Related]
14. C-type lectin LSECtin interacts with DC-SIGNR and is involved in hepatitis C virus binding.
Li Y; Hao B; Kuai X; Xing G; Yang J; Chen J; Tang L; Zhang L; He F
Mol Cell Biochem; 2009 Jul; 327(1-2):183-90. PubMed ID: 19234677
[TBL] [Abstract][Full Text] [Related]
15. Signaling of extracellular inorganic phosphate up-regulates cyclin D1 expression in proliferating chondrocytes via the Na+/Pi cotransporter Pit-1 and Raf/MEK/ERK pathway.
Kimata M; Michigami T; Tachikawa K; Okada T; Koshimizu T; Yamazaki M; Kogo M; Ozono K
Bone; 2010 Nov; 47(5):938-47. PubMed ID: 20709201
[TBL] [Abstract][Full Text] [Related]
16. IL-29 and IFN-α regulate the expression of MxA, 2',5'-OAS and PKR genes in association with the activation of Raf-MEK-ERK and PI3K-AKT signal pathways in HepG2.2.15 cells.
Chai Y; Huang HL; Hu DJ; Luo X; Tao QS; Zhang XL; Zhang SQ
Mol Biol Rep; 2011 Jan; 38(1):139-43. PubMed ID: 20309637
[TBL] [Abstract][Full Text] [Related]
17. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus.
Gardner JP; Durso RJ; Arrigale RR; Donovan GP; Maddon PJ; Dragic T; Olson WC
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4498-503. PubMed ID: 12676990
[TBL] [Abstract][Full Text] [Related]
18. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.
Poulikakos PI; Zhang C; Bollag G; Shokat KM; Rosen N
Nature; 2010 Mar; 464(7287):427-30. PubMed ID: 20179705
[TBL] [Abstract][Full Text] [Related]
19. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
[TBL] [Abstract][Full Text] [Related]
20. Involvement of ERK pathway in interferon alpha-mediated antiviral activity against hepatitis C virus.
Zhao LJ; Wang W; Wang WB; Ren H; Qi ZT
Cytokine; 2015 Mar; 72(1):17-24. PubMed ID: 25544181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
